Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2030.63 (Glytoucan)

Id:00dbfd23-c49e-5635-a631-19b04697f2f3

Glytoucan:G58753AP

Results found

Linked to

	Label	Description
	2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G65969HW-GLYCOSEQ00003181 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has canonical residue n-glycan b-d-glcpnac 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G65117HG-GLYCOSEQ00026917 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G89911NQ-GLYCOSEQ00032126 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G65117HG-GLYCOSEQ00026919 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has canonical residue n-glycan a-d-manp 4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G58753AP-GLYCOSEQ00154741 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G87404HF-GLYCOSEQ00067082 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G65969HW-GLYCOSEQ00003181 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has canonical residue n-glycan b-d-glcpnac 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G65117HG-GLYCOSEQ00026917 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G89911NQ-GLYCOSEQ00032126 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G65117HG-GLYCOSEQ00026919 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has canonical residue n-glycan a-d-manp 4

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G58753AP-GLYCOSEQ00154741 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2030.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G87404HF-GLYCOSEQ00067082 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.